Lactobacillus reutri have been shown to promote anti-tumor immunity in breast cancer by promoting interferon-γ-producing CD8+T cells and its derived tryptophan metabolite was demonstrated to enhance ICI therapy (Bender et al., 2023a, Bender et al., 2023b). The gene discussed is CD8A; the disease is neoplasm.